Mannose-binding lectin (MBL) plays an important role in the early stages of primary infections and during the decay of maternal antibodies in infants. Various studies have looked at the relation between serum MBL concentrations, MBL gene alterations and susceptibility to infections. We investigated the distribution of variant MBL alleles in 626 unrelated adults from sub-Saharan African countries and looked for a potential relation between these alleles and the incidence, prevalence and death rate of tuberculosis for sub-Saharan Africa. We also evaluated the relation between MBL genotypes and susceptibility to HIV-1 infection in 188 Gabonese adults. We found that (i) the prevalence of the common variant MBL alleles is correlated with the incidence of tuberculosis in sub-Saharan Africa (r ¼ 0.565), (ii) the mutant MBL G57E allele, in either the homozygous or compound heterozygous state, is associated with susceptibility to HIV-1 infection in the Gabonese population (P ¼ 0.019).Our data plus those in the literature suggest that individuals who are homozygous for the mutant MBL alleles display increased susceptibility to infections. Interestingly, we found that individuals who are heterozygous for MBL mutations are much less susceptible to infections than those who are homozygous for the wild-type MBL allele.
Introduction
The mannose-binding lectin (MBL), or mannan-binding protein, is a calcium-dependent serum lectin secreted by hepatocytes. The human MBL gene is located on the long arm of chromosome 10 (10q11.2). It is B7 kb in size and has four exons. 1 The primary structure of MBL can be divided into several domains: a signal peptide, a cysteine-rich region, a collagenous domain, a neck region (a-helix) and a carbohydrate-binding domain. 2 MBL plays an opsonic role in host defense against pathogens bearing surface-exposed mannose residues. Its role consists in enhancing the attachment, ingestion and killing of opsonized pathogens by phagocytes. 3 MBL also activates the complement system by virtue of its sugar-binding function in conjunction with a C1-like serine protease called the MBL-associated serine protease (MASP). 4 MBL is functionally analogous (i) to IgM because of its carbohydrate recognition domain (CRD), (ii) to IgG because of its opsonic role and (iii) to C1q because of its ability to interact with MASP. 5 MBL is believed to be particularly important in the early stages of primary infections and during the 'window of vulnerability' experienced by infants during the decay of maternal antibodies. 5 Low serum MBL concentrations result in a defect in opsonization and a significant correlation exists between serum MBL concentrations, the generation of C3b opsonins and a point mutation at codon 54 in exon 1 of the MBL gene (GGC-GAC), designated G54D. 6, 7 A second point mutation, first described in Gambians, at codon 57 of exon 1 (GGA-GAA) (G57E), is believed to disrupt the secondary structure of the collagenous triple helix of the MBL subunits, in the same manner as the G54D allele. 8 A study in Kenyan and Danish populations revealed the presence of a third point mutation (R52C) at codon 52 (CGT-TGT). 9 Two additional polymorphisms, at positions À550 (H/L variant) and À221 (X/Y variant) in the promoter region of the MBL gene, generate four different promoter haplotypes (HX, HY, LX and LY). The HY, LY and LX haplotypes are associated with high, medium and low serum MBL concentrations, respectively. 10 Trans-racial studies have looked at the association between the status of MBL protein production, the MBL genotype and the clinical phenotype. The median MBL protein concentration is approximately five times lower among Africans than among Eskimos. 11 African subjects who are homozygous or heterozygous for the G57E allele have severely reduced MBL serum concentrations and hence a reduced capacity to activate the complement system. 8 Other studies in Africans have suggested that MBL is involved in the pathogenesis of tuberculosis, but the relation remains to be confirmed. 12, 13 MBL appears to recognize selectively high-mannose glycans found on the surface of the envelope glycoprotein of viruses such as HIV. 3 In vitro studies have suggested that MBL recognizes a domain of the mannose glycans on the gp120 envelope protein that is recognized by CD4. This in turn suggests that MBL can inhibit the entry of the virus into the cells. 14 These assumptions led to studies on the relation between MBL serum concentrations, MBL gene mutations and susceptibility to HIV. However, most of these studies were carried out on Caucasian populations. 15, 16 No such studies have been carried out on Africans, even though they have a different prevalent mutant MBL allele (G57E).
The aim of this study was to establish the distribution profile of MBL alleles in sub-Saharan African population groups and then to analyze the influence of mutant MBL alleles on the incidence, prevalence and death rate of tuberculosis. We also evaluated the relation between MBL genotypes and susceptibility to HIV-1 infection in a Black African population from Gabon.
Results

MBL alleles in sub-Saharan Africa
The frequencies of the common variant MBL alleles (G54D and G57E) in African populations are summarized in Table 1a . In these sub-Saharan African samples, both the common G54D and G57E alleles followed the expected Hardy-Weinberg proportions. The frequency of the variant MBL alleles differed significantly between West Africa and Central Africa (0.33 vs 0.21, respectively; Po0.05). The MBL R52C allele was not detected in individuals from West Africa or Central Africa. In all of the African countries studied, except Djibouti, the MBL G57E allele was significantly more prevalent than the G54D allele (0.28 vs 0.02, respectively; Po0.0001).
Two novel variants were detected in subjects from West and Central Africa, because of their atypical denaturing gradient gel electrophoresis (DGGE) profiles (Figure 1) , and both were found to consist of a G-A transition. The first variation (R52H), located at codon 52 of exon 1 (nucleotide position 155 of the open reading frame), caused an amino-acid change (arginine to histidine). The second variation (IVS-I-5 G-A) was located in the splice consensus sequence of the first intron at position 5. In both cases, the sequence change creates an NlaIII restriction site. Thus, this restriction enzyme was used to confirm the sequence variations. The representative restriction profiles are given in Figure 2 . We found that the MBL IVS-I-5 G-A allele was much more frequent in Central African samples (2.3%) than in West African samples (0.5%). The R52H allele was rarely detected. In fact, it was only detected in Gabonese samples (2/428) and exclusively among subjects heterozygous for the G57E allele. The R52H and G57E mutations were found to be in trans position. The new R52H mutation (CGT-CAT) affects the second nucleotide of the same codon affected by the R52C mutation (CGT-TGT).
MBL alleles and tuberculosis in sub-Saharan Africa
The common MBL alleles (G54D and G57E) were most frequent in West Africa (33%). The incidence of tuberculosis is also high in this region (4250 per 100 000). 17 In contrast, the Central African region has both a low MBL variant allele frequency (21%) and a low tuberculosis incidence (100-249 per 100 000). 17 Table 1b summarizes the results of the evaluation of MBL (G54D and G57E) alleles and tuberculosis parameters in all subjects (West and Central Africa). We found a significant correlation between the prevalence of the common variant MBL alleles and the incidence of tuberculosis (r ¼ 0.565; t ¼ 2.273 with n ¼ 13; Pearson's test). However, the prevalence of the common variant MBL alleles was not correlated with the estimated death rate due to tuberculosis (r ¼ 0.226; Pearson's test).
MBL genotypes and HIV-1 infection in the Gabonese population MBL genotyping was performed in HIV-1-positive (n ¼ 68) and HIV-1-negative (n ¼ 120) Gabonese subjects. The frequency of the variant MBL alleles in HIV-1-infected and -uninfected subjects did not differ significantly (0.206 and 0.167, respectively; Table 2a ). However, all subjects who were homozygous for G57E or compound heterozygous for G57E and G54D were HIV-1-positive. An association was found between these MBL genotypes and HIV-1 status (Fisher's exact test; P ¼ 0.019). In contrast, there was no association between the G57E allele in the heterozygous state and susceptibility to HIV-1 infection.
In the uninfected group, the observed G57E allele distribution was significantly different from the expected Hardy-Weinberg distribution (w 2 test; P ¼ 0.05). This was not the case in the HIV-1-infected group (Table 2b ). In fact, individuals who were heterozygous for the G57E allele were over-represented in the HIV-1-uninfected group, whereas subjects who were homozygous for the G57E allele were underrepresented.
Discussion
MBL alleles in sub-Saharan Africa
There is a significant difference in the prevalence of variant MBL alleles between West and Central Africa (33 vs 21%, respectively). A similar high prevalence rate has also been found in South Africa (27%). 18 In this context, it is of particular interest to note that in South American populations, low serum MBL concentrations were primarily because of G54D mutation while in East Africa it is because of G57E mutation in combination with relatively high frequency of low-producing promoter haplotypes. 19 Taken together, these data suggest that the MBL G57E mutation is indeed of sub-Saharan African origin and is the most ancient mutation, given its widespread distribution throughout Africa. In contrast, two novel mutations (R52H and IVS-I-5 G-A) might have arisen more recently, which explains why their distribution is restricted to Central Africa.
The MBL IVS-I-5 G-A mutation is located in the splice donor site of intron I. A mutation at the same position in the human b-globin gene results in impaired splicing and decreased synthesis of the b-globin chain. 20 Hence, it is reasonable to postulate that this mutation in the MBL gene affects the synthesis of the MBL protein.
Like the R52C mutation, the R52H mutation results in an amino-acid change in the collagenous region, but the former substitution at this position does not seem to disrupt the Gly-Xaa-Yaa repeated structure. 9 Although the newly substituted histidine is basic like arginine, it may differ from arginine in its interactions with other amino acids during the assembly of polypeptide chains and hence may have a negative effect on the stability of the multimer. Consequently, individuals who are compound heterozygous for G57E and R52H may lack MBL in the serum, as is the case with subjects who are compound heterozygous for G57E and R52C. 9 Interestingly, R52C mutation was found to be associated with the same haplotype that is associated with G57E, the most common allele in this region (unpublished observation).
MBL alleles and tuberculosis
The overall frequency of mutant MBL alleles (29%) was high in sub-Saharan Africans. In other populations, the combined frequency of the G57E and G54D alleles is as follows: Eskimos (13%), 11 Hong Kong Chinese (17%), 8 British Caucasians (11%), 8 Danes (15%), 6 and hence markedly lower than in Africans. Differences between variant MBL allele frequencies in Africans and in nonAfricans are supported by the finding that the median MBL blood concentrations in Africans are two-fold lower than in Caucasians and five-fold lower than in Eskimos. 11 The high frequencies of variant MBL alleles in Africa suggest that these alleles may confer selective advantages.
In fact, in South Africa, a significant association was observed between the G54D allele and protection against the development of two forms of tuberculosis (tuberculous meningitis and pulmonary tuberculosis). 12 In Gambia, the G57E allele is weakly associated with resistance to tuberculosis and in Tanzania, a high serum concentration of MBL is associated with increased susceptibility to tuberculosis. 13, 21 In subjects homozygous for MBL wild-type alleles, the MBL protein (at normal/ high serum concentrations) may activate the classical complement pathway, bind pathogenic mycobacteria efficiently and thus favor their spread. 22 In contrast, in individuals with variant MBL alleles and consequently low MBL serum concentrations, this process may be hampered.
Our findings reveal a correlation between the frequencies of the common variant MBL alleles and the incidence of tuberculosis in sub-Saharan Africa and support the hypothesis that variant MBL alleles are associated with protection against tuberculosis. In other words, tuberculosis infection may be one of the driving forces in variant MBL allele selection. In addition, the findings that MBL deficiency is associated with resistance against leprosy and leishmaniasis suggest that MBL deficiency confers selective advantages against intracellular pathogens.
23,24
The high prevalence of infections caused by intracellular pathogens in Africa may explain the elevated frequency of alleles causing low levels of MBL as compared to in Europe.
MBL alleles and HIV-1 infection
The second part of our study revealed that being homozygous or compound heterozygous for the G57E allele is associated with an increased risk of HIV-1 infection. In this context, it is noteworthy that in individuals with these genotypes, the MBL protein is either undetectable or only present in trace amounts (o20 mg/1). 9 Furthermore, low serum MBL concentrations are associated with impairment, of phagocytosis by polymorphonuclear leukocytes. 6 Hence, subjects who are homozygous or compound heterozygous for the variant MBL alleles may have an opsonic impairment, and hence be unable to clear pathogens bearing surface-exposed mannose residues such as HIV. In vitro studies support this hypothesis, showing that MBL selectively recognizes high-mannose glycans on the gp120 expressed on the surface of HIV-infected cells and by opsonizationinhibited HIV infection.
14 A more recent study showed that CCR5-tropic and CXCR4-tropic primary isolates of HIV-1, as well as macrophage-tropic virus strains bind MBL through CRD. 25 This study suggested that the MBL can selectively interact with HIV in vivo via CRD on gp120/gp41. An association has also been detected between susceptibility to HIV-1 infection, progression of AIDS and variant MBL alleles. 15 This association is essentially strong among Caucasian populations, in which the G54D allele is the most prevalent. Our study concerned a native African population in which the G57E allele is the most prevalent. Such trans-racial confirmation of the role of MBL variants in HIV susceptibility highlights the importance of this locus in HIV infection.
MBL genotypes and infections
In the HIV-uninfected group, markers such as the CCR2 64I allele follow the expected Hardy-Weinberg proportions (unpublished data). Thus, the over-representation of subjects heterozygous for the G57E allele in the HIV-1-uninfected group may correspond to decreased susceptibility of such subjects to HIV-1 infection. This is further supported by the finding that HIV-1-infected men with variant MBL alleles (95% of whom were heterozygote) progressed more slowly to AIDS and death. 26 We previously reported that the variant MBL alleles, mainly in the heterozygous state, are prevalent in patients with sickle cell anemia who had not suffered severe infections. 27 Similarly, other studies have demonstrated that heterozygotes are protected against tuberculosis infection. 12, 13 This protective effect contrasts with the increased susceptibility of homozygotes (for the mutant MBL alleles) to various infections. [28] [29] [30] [31] Similarly, subjects homozygous for the wild-type MBL allele display an increased risk of bacterial infections including tuberculosis. 12, 13, 32 To summarize, susceptibility to various infections, including HIV, increases progressively with the following MBL genotypes: (i) heterozygotes, (ii) homozygous for wild-type allele and (iii) homozygous or compound heterozygous for the mutant alleles. The positive selection of the heterozygous MBL genotype may explain the high variant MBL allele frequencies in Africa. This phenomenon reflects the notion of heterosis as observed with the sickle cell trait. 23 In conclusion, our study indicates that the frequency of variant MBL alleles, mainly G57E, is highest in subSaharan Africa and that the wide-spread nature of tuberculosis infection in this area may be one of the driving forces selecting these mutant alleles. In addition, the G57E allele in the homozygous or compound heterozygous state is associated with an increased risk of HIV-1 infection in Africans. The concept of a balanced polymorphism (the deleterious effects of the mutant homozygotes in terms of high susceptibility to infections is outweighed by the advantageous effects of heterozygotes) is probably applicable to the MBL gene, with an interesting extension towards homozygotes for the wildtype alleles. If this is indeed the case, the prevalence of mutant MBL alleles will continue to increase. Further, large-scale, long-term studies are needed to monitor this trend.
Materials and methods
Collection of blood samples
We studied two distinct cohorts in the two parts of this study.
1. For the first part, 626 blood samples were collected from randomly selected adults from 16 African countries (located in West, Central and East Africa and in the Indian Ocean region). Most of individuals come from Central African countries, particularly Gabon (214), and from West African countries, namely Ivory Coast (150).
2. To study the relation between MBL genotypes and HIV-1 infection in Gabon, two groups of individuals were recruited. The first group consisted of 120 HIV-1 seronegative individuals living in the city of Port-Gentil (Western Gabon) but originating from different parts of Gabon. The second group included 68 HIV-1 seropositive subjects from the major cities of Gabon (Libreville, PortGentil, Franceville). Seropositivity was confirmed by Western blotting with an anti-HIV-1 antibody (Sanofi Diagnostic Pasteur, Paris, France).
DNA was extracted from all blood samples by the phenol/chloroform procedure. Informed consent was obtained from all participants. The study design was approved by the institutional ethical committee of the CIRMF (International Center of Medical Research of Franceville, Franceville, Gabon).
Analysis of mutations
We used DGGE to screen for the different MBL alleles and subsequent sequencing were performed as described by Gabolde et al. 33 PCR-restriction fragment length polymorphism (RFLP) analysis was carried out as described by Lipscombe et al. 8 with a minor modification; a 340-bp fragment was amplified instead of a 328-bp fragment using the following primers: MBP2: 5 0 CAGGCAGTTTCCTCTGGAAGG3 0 (reverse), MBP3: 5 0 GCACCCAGATTGTAGGACAGAG3 0 (forward). Site-directed mutagenesis (SDM) was carried out as described by Madsen et al.
9
Statistical analysis Pearson's test was used to study the correlation between MBL alleles and the incidence, prevalence and death rate of tuberculosis. Fisher's exact test was used to study the association between MBL genotypes and HIV-1 infection. w 2 test was used to compare the observed and expected frequencies of the G57E allele.
